Anacetrapib - CISMeF

Preferred Label : Anacetrapib;

NCIt definition : A cholesteryl ester transfer protein (CETP) inhibitor with hypocholesterolemic properties. Anacetrapib reduces the transfer of cholesteryl ester from HDL to LDL and/or VLDL thereby, producing an increase in serum HDL-cholesterol levels and a decrease in serum LDL-cholesterol levels. This agent has not yet been shown to reduce deaths associated with hypercholesterolemia.;

UNII : P7T269PR6S;

InChIKey : MZZLGJHLQGUVPN-HAWMADMCSA-N;

CAS number : 875446-37-0;

Chemical formula : C30H25F10NO3;

Détails

Origin ID

C75251;

UMLS CUI

C2604745;

Currated CISMeF NLP mapping
- anacetrapib [MeSH concept]
- anacetrapib [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- anacetrapib [MeSH concept]
- anacetrapib [MeSH Supplementary Concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients